Paper21069
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Davis JM and 1 other. Drugs, 1977. Cited by 84 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antipsychotic drugs: clinical pharmacology and therapeutic use. Papers, record 21069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21069
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Psychotic Disorders | Major topic |
| Chlorpromazine | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Drug Hypersensitivity | |
| Drug Therapy, Combination | |
| Dyskinesia, Drug-Induced | |
| Hemodynamics | |
| Humans | |
| Recurrence | |
| Schizophrenia |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,498,342 | A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients. | J Clin Exp Psychopathol Q Rev Psychiatry Neurol | 1961 | https://conductscience.org/library/papers/14498342 | PubMed |
| 2 | 4,948,596 | Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients. | Behav Neuropsychiatry | 1971 | https://conductscience.org/library/papers/4948596 | PubMed |
| 3 | 14,270,524 | CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT. | Br J Psychiatry | 1965 | https://conductscience.org/library/papers/14270524 | PubMed |
| 4 | 4,571,196 | Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. | Br Med J | 1973 | https://conductscience.org/library/papers/4571196 | PubMed |
| 5 | 1,097,221 | Loxapine succinate: a controlled double-blind study in chronic schizophrenia. | Dis Nerv Syst | 1975 | https://conductscience.org/library/papers/1097221 | PubMed |
| 6 | 4,629,112 | A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients. | Curr Ther Res Clin Exp | 1972 | https://conductscience.org/library/papers/4629112 | PubMed |
| 7 | 13,859,388 | A study of phenothiazines with male and female chronically ill schizophrenic patients. | J Nerv Ment Dis | 1962 | https://conductscience.org/library/papers/13859388 | PubMed |
| 8 | 4,589,978 | Evaluation of loxapine succinate in chronic schizophrenia. | Dis Nerv Syst | 1972 | https://conductscience.org/library/papers/4589978 | PubMed |
| 9 | 1,092,725 | Loxapine in newly admitted chronic schizophrenic patients. | J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1092725 | PubMed |
| 10 | 5,048,301 | Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis. | Clin Sci | 1972 | https://conductscience.org/library/papers/5048301 | PubMed |
| 11 | 14,141,840 | DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS. | J Chronic Dis | 1964 | https://conductscience.org/library/papers/14141840 | PubMed |
| 13 | 4,917,090 | Molindone in chronic schizophrenia. | Clin Pharmacol Ther | 1970 | https://conductscience.org/library/papers/4917090 | PubMed |
| 14 | 8,025 | Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions. | Arch Gen Psychiatry | 1976 | https://conductscience.org/library/papers/8025 | PubMed |
| 15 | 4,374,155 | Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. | Arch Gen Psychiatry | 1974 | https://conductscience.org/library/papers/4374155 | PubMed |
| 16 | 4,869,439 | A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia. | Am J Psychiatry | 1968 | https://conductscience.org/library/papers/4869439 | PubMed |
| 17 | 14,089,354 | PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP. | Arch Gen Psychiatry | 1964 | https://conductscience.org/library/papers/14089354 | PubMed |
| 18 | 809,232 | Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine. | Curr Ther Res Clin Exp | 1975 | https://conductscience.org/library/papers/809232 | PubMed |
| 19 | 4,601,554 | Trifluoperazine: a comparison between regular and high doses. | Psychopharmacologia | 1974 | https://conductscience.org/library/papers/4601554 | PubMed |
| 20 | 4,631,378 | Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients. | Curr Ther Res Clin Exp | 1973 | https://conductscience.org/library/papers/4631378 | PubMed |
| 21 | 4,917,354 | Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study. | J Clin Pharmacol J New Drugs | 1970 | https://conductscience.org/library/papers/4917354 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,152,472 | Hippocampal subfield transcriptome analysis in schizophrenia psychosis. | Mol Psychiatry | 2021 | https://conductscience.org/library/papers/32152472 | PubMed |
| 30,572,373 | Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/30572373 | PubMed |
| 30,480,760 | Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/30480760 | PubMed |
| 27,078,222 | Risperidone (depot) for schizophrenia. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27078222 | PubMed |
| 25,760,334 | Drug repurposing for the treatment of staphylococcal infections. | Curr Pharm Des | 2015 | https://conductscience.org/library/papers/25760334 | PubMed |
| 24,644,460 | Early onset priapism under chlorpromazine and risperidone therapy. | Iran J Psychiatry Behav Sci | 2011 | https://conductscience.org/library/papers/24644460 | PubMed |
| 22,513,966 | Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22513966 | PubMed |
| 22,345,836 | A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia. | Indian J Psychol Med | 2011 | https://conductscience.org/library/papers/22345836 | PubMed |
| 22,034,474 | Treatment of the special patient with schizophrenia. | Dialogues Clin Neurosci | 2001 | https://conductscience.org/library/papers/22034474 | PubMed |
| 22,034,144 | Treatment-refractory schizophrenia. | Dialogues Clin Neurosci | 2004 | https://conductscience.org/library/papers/22034144 | PubMed |
| 21,279,034 | Reducing the number of anticonvulsant drugs taken by severely retarded epileptic patients. | Can Fam Physician | 1984 | https://conductscience.org/library/papers/21279034 | PubMed |
| 20,531,374 | Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia. | Pharmacogenomics J | 2011 | https://conductscience.org/library/papers/20531374 | PubMed |
| 20,021,320 | Effect of second-generation antipsychotics on cognition: current issues and future challenges. | Expert Rev Neurother | 2010 | https://conductscience.org/library/papers/20021320 | PubMed |
| 18,646,161 | Aripiprazole versus typical antipsychotic drugs for schizophrenia. | Cochrane Database Syst Rev | 2008 | https://conductscience.org/library/papers/18646161 | PubMed |
| 17,253,464 | Depot fluspirilene for schizophrenia. | Cochrane Database Syst Rev | 2007 | https://conductscience.org/library/papers/17253464 | PubMed |
| 16,625,607 | Aripiprazole for schizophrenia. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/16625607 | PubMed |
| 10,796,543 | Risperidone versus typical antipsychotic medication for schizophrenia. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/10796543 | PubMed |
| 6,808,540 | Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6808540 | PubMed |
| 6,110,534 | Psychotherapeutic drugs: important adverse reactions and interactions. | Drugs | 1980 | https://conductscience.org/library/papers/6110534 | PubMed |
| 2,292,234 | Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. | Drugs | 1990 | https://conductscience.org/library/papers/2292234 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21069
GET https://conductscience.org/api/papers/v1/21069/references?page=2